
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
Angela Pearce, Bronwyn Terrill, Jan‐Willem C. Alffenaar, et al.
Internal Medicine Journal (2022) Vol. 52, Iss. 7, pp. 1135-1143
Open Access | Times Cited: 19
Angela Pearce, Bronwyn Terrill, Jan‐Willem C. Alffenaar, et al.
Internal Medicine Journal (2022) Vol. 52, Iss. 7, pp. 1135-1143
Open Access | Times Cited: 19
Showing 19 citing articles:
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives
Petar Brlek, Luka Bulić, Matea Bračić, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 504-504
Open Access | Times Cited: 37
Petar Brlek, Luka Bulić, Matea Bračić, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 504-504
Open Access | Times Cited: 37
Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review
Amanda Wondrasek, Amber Fryza, Md. Abdul Aziz, et al.
Health Science Reports (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Amanda Wondrasek, Amber Fryza, Md. Abdul Aziz, et al.
Health Science Reports (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Pharmacogenomics – a minor rather than major force in clinical medicine
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
Susanne B. Haga
Pharmacy (2023) Vol. 11, Iss. 5, pp. 144-144
Open Access | Times Cited: 10
Susanne B. Haga
Pharmacy (2023) Vol. 11, Iss. 5, pp. 144-144
Open Access | Times Cited: 10
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
Marliese Alexander, Chiao Xin Lim, Senthil Lingaratnam, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Marliese Alexander, Chiao Xin Lim, Senthil Lingaratnam, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Implementing CYP2C19-guided clopidogrel therapy: a scoping review of pharmacogenomic testing services
Trishna Patel, Eman Wehbe, Stephen Hughes, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 3
Open Access
Trishna Patel, Eman Wehbe, Stephen Hughes, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 3
Open Access
How equipped are pharmacists for pharmacogenomics?: A cross-sectional study on knowledge, attitudes, and implementation practices in Saudi Arabia
Mohammed Alharthi
Medicine (2025) Vol. 104, Iss. 17, pp. e42240-e42240
Open Access
Mohammed Alharthi
Medicine (2025) Vol. 104, Iss. 17, pp. e42240-e42240
Open Access
Healthcare professionals' and consumers' knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: A systematic review
Chiao Xin Lim, Alistair Bozkurt, Zi-yue Chen, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 12, pp. 2467-2482
Open Access | Times Cited: 9
Chiao Xin Lim, Alistair Bozkurt, Zi-yue Chen, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 12, pp. 2467-2482
Open Access | Times Cited: 9
One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?
Yudisia Ausi, Melisa Intan Barliana, Maarten J. Postma, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 4863-4874
Open Access | Times Cited: 3
Yudisia Ausi, Melisa Intan Barliana, Maarten J. Postma, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 4863-4874
Open Access | Times Cited: 3
A Scoping Review of Pharmacogenomic Educational Interventions to Improve Knowledge and Confidence
Ruby Soueid, Toni J. F. Michael, Rose Cairns, et al.
American Journal of Pharmaceutical Education (2024) Vol. 88, Iss. 3, pp. 100668-100668
Open Access | Times Cited: 2
Ruby Soueid, Toni J. F. Michael, Rose Cairns, et al.
American Journal of Pharmaceutical Education (2024) Vol. 88, Iss. 3, pp. 100668-100668
Open Access | Times Cited: 2
ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels
Subrata Deb, Robert Hopefl, Anthony Allen Reeves, et al.
Medicines (2024) Vol. 11, Iss. 3, pp. 6-6
Open Access | Times Cited: 2
Subrata Deb, Robert Hopefl, Anthony Allen Reeves, et al.
Medicines (2024) Vol. 11, Iss. 3, pp. 6-6
Open Access | Times Cited: 2
Calculation of the pharmacogenomics benefit score for patients with medication-related problems
Thomas M. Polasek
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Thomas M. Polasek
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
A national-wide survey on clinical implementation of PGx testing into precision therapeutics for Chinese children: a long way before standard clinical practice
Wenwen Wu, Hong‐Li Guo, Yue Li, et al.
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Wenwen Wu, Hong‐Li Guo, Yue Li, et al.
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients
Catherine R. Virelli, Mahbod Ebrahimi, Ayeshah G. Mohiuddin, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 22-22
Open Access | Times Cited: 2
Catherine R. Virelli, Mahbod Ebrahimi, Ayeshah G. Mohiuddin, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 22-22
Open Access | Times Cited: 2
Clinical Pharmacists’ Knowledge of and Attitudes toward Pharmacogenomic Testing in China
Xiaoyan Nie, Tong Jia, Xiaowen Hu, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1348-1348
Open Access | Times Cited: 3
Xiaoyan Nie, Tong Jia, Xiaowen Hu, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1348-1348
Open Access | Times Cited: 3
A national-wide survey on clinical implementation of pharmacogenetic testing into precision therapeutics for Chinese children: A long way before standard clinical practice
Wenwen Wu, Hong‐Li Guo, Yue Li, et al.
Research Square (Research Square) (2024)
Open Access
Wenwen Wu, Hong‐Li Guo, Yue Li, et al.
Research Square (Research Square) (2024)
Open Access
Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis
Dean Kaptsis, Martin Lewis, Michael J. Sorich, et al.
Journal of Psychopharmacology (2024)
Closed Access
Dean Kaptsis, Martin Lewis, Michael J. Sorich, et al.
Journal of Psychopharmacology (2024)
Closed Access
Consultation informs strategies to improve functional evidence use in variant classification
Rehan M. Villani, Bronwyn Terrill, Emma Tudini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rehan M. Villani, Bronwyn Terrill, Emma Tudini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting
Rosalind Moxham, Andrew Tjokrowidjaja, Sophie Devery, et al.
World Journal of Medical Genetics (2023) Vol. 11, Iss. 4, pp. 39-50
Open Access
Rosalind Moxham, Andrew Tjokrowidjaja, Sophie Devery, et al.
World Journal of Medical Genetics (2023) Vol. 11, Iss. 4, pp. 39-50
Open Access